Low dose resveratrol treatment can restore the fatty acid oxidation level of myocardial infarction rats, significantly improve cardiac energy metabolism, significantly inhibit cytochrome P450 1B1 (CYP1B1) and cardiotoxic hydroxyeicosatetraenoic acid (HETE) metabolites induced by myocardial infarction rats, significantly improve ejection fraction and inhibit cardiac remodeling (Matsumura et al., 2018a). This evidence concerns the gene CYP1B1 and myocardial infarction.